Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model.
about
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumoniaAdjunctive Hyperbaric Oxygen Therapy or Alone Antibiotherapy? Methicillin Resistant Staphylococcus aureus Mediastinitis in a Rat Model.[Rational antibiotic treatment of mediastinitis].Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis.
P2860
Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Ceftobiprole medocaril is an e ...... mediastinitis in a rat model.
@en
Ceftobiprole medocaril is an e ...... esistant Staphylococcus aureus
@nl
type
label
Ceftobiprole medocaril is an e ...... mediastinitis in a rat model.
@en
Ceftobiprole medocaril is an e ...... esistant Staphylococcus aureus
@nl
prefLabel
Ceftobiprole medocaril is an e ...... mediastinitis in a rat model.
@en
Ceftobiprole medocaril is an e ...... esistant Staphylococcus aureus
@nl
P2093
P2860
P1476
Ceftobiprole medocaril is an e ...... mediastinitis in a rat model.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10096-013-1959-9
P577
2013-09-14T00:00:00Z
P6179
1002189002